Shanmuga Hospital reported a stable financial performance for FY26, with net profit remaining largely unchanged year-on-year. The Salem-based healthcare provider recorded revenue from operations of ₹4,743.61 lakh and a profit after tax (PAT) of ₹421.06 lakh for the year ended March 31, 2026.

The results reflect the company's transition into its first full fiscal year as a listed entity on the BSE SME Platform. While operating income saw a marginal decline compared to the previous year, the hospital maintained profitability despite significant capital investments in advanced medical technology.

Financial Performance

Revenue from operations stood at ₹4,743.61 lakh, a slight decrease from ₹4,785.33 lakh in FY25. Total income for the period was ₹4,806.32 lakh, driven by other income which rose to ₹62.71 lakh from ₹23.35 lakh in the prior year.

EBITDA expanded to ₹885.42 lakh from ₹840.44 lakh, indicating improved operational efficiency before interest, taxes, depreciation, and amortization. The cost of consumption decreased significantly to ₹1,474.72 lakh from ₹1,772.74 lakh, contributing to margin stability.

Capital Expenditure and IPO Utilization

A key development during the year was the full utilization of Initial Public Offer (IPO) proceeds. The company raised ₹2,061.72 lakh through its IPO in FY25. As of March 31, 2026, the entire amount had been deployed, with ₹1,115.50 lakh utilized specifically for capital expenditure during FY26.

This capital deployment facilitated the acquisition and operationalization of the Da Vinci Xi Robotic Surgical System, marking a significant milestone in the hospital's clinical capabilities. Property, Plant, and Equipment (PPE) increased substantially to ₹3,746.89 lakh from ₹2,242.71 lakh, reflecting these strategic investments.

Operational Highlights

The hospital reported over 4,200 admissions and performed more than 2,500 surgeries during the year. The introduction of robotic-assisted surgery has enabled precision-driven procedures across multiple specialties, including urology, gynaecology, and oncology. The facility also maintained an average length of stay (ALOS) of 2.6 days, demonstrating efficient patient flow management.

What the Numbers Show

Despite a slight dip in top-line revenue, the hospital achieved higher EBITDA, suggesting improved cost control or a shift in service mix towards higher-margin procedures. The significant reduction in cost of consumption (₹298 lakh decrease) contrasts with rising employee benefit expenses (₹198.73 lakh increase), highlighting a strategic shift towards human capital investment alongside technological upgrades. The complete deployment of IPO proceeds into capital assets indicates a focus on long-term capacity building rather than short-term liquidity retention.

Shanmuga Hospital Limited reported a net profit of ₹98.65 lakh for the quarter ended June 30, 2026 (Q1FY27), a 3.9% year-on-year increase from ₹94.98 lakh in Q1FY26. The gain was supported by a 3.4% rise in revenue from operations to ₹1,186.71 lakh and a sharp decline in cost of consumption. Alongside the financial results, the Board approved a power purchase agreement (PPA) with LNGS Private Limited, formulated the Shanmuga Hospital Limited Employee Stock Option Plan 2026 (SHL ESOP-2026), and proposed an increase in authorized share capital to ₹25 crore.

The Board meeting held on August 11, 2026, approved the unaudited standalone financial results as recommended by the Audit Committee. The results were subjected to a limited review by P P N And Company, the statutory auditors, in compliance with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company voluntarily disclosed these quarterly figures under the SME Listing framework to enhance investor transparency.

Financial Performance

Revenue from operations increased to ₹1,186.71 lakh in Q1FY27 from ₹1,148.21 lakh in Q1FY26. Total income for the quarter stood at ₹1,190.98 lakh, including other income of ₹4.27 lakh. Operating expenses were managed effectively, with cost of consumption declining significantly to ₹268.72 lakh from ₹381.41 lakh in the prior year period. However, employee benefits expenses rose to ₹221.68 lakh from ₹140.63 lakh, reflecting investments in human resources.

Profit before tax rose marginally by 1.3% to ₹131.56 lakh. Tax expense for the quarter was ₹32.91 lakh, comprising current tax of ₹22.90 lakh and deferred tax of ₹10.01 lakh. Earnings per share (EPS) stood at ₹0.72, compared to ₹0.70 in the same quarter last year.

Strategic Approvals and Corporate Actions

The Board entered into a power purchase agreement (PPA) with LNGS Private Limited for the procurement of electricity at a tariff of ₹6.10 per unit. As a condition precedent to the PPA, the company will invest 1% of the paid-up share capital of LNGS Private Limited. Dr. P. Prabu Sankar Panneerselvam, Executive Director & CEO, was authorized to negotiate and execute the agreement.

Additionally, the Board approved the "Shanmuga Hospital Limited Employee Stock Option Plan 2026" (SHL ESOP-2026) under the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. The plan allows for the grant of up to 3,50,000 equity shares, representing 2.58% of the total paid-up equity share capital. Options will vest between one and three years from the date of grant. M/s Finshore Management Service Ltd. was appointed as the merchant banker for the ESOP.

The Board also approved an increase in authorized share capital from ₹14 crore (1,40,00,000 equity shares) to ₹25 crore (2,50,00,000 equity shares). This proposal, along with alterations to the Main Object Clause of the Memorandum of Association (MOA) and amendments to the Articles of Association (AOA), requires shareholder approval at the upcoming Annual General Meeting (AGM). The new MOA clauses enable the company to provide support services to medical institutions and deal in software and digital solutions.

What the Numbers Show

The divergence between revenue growth and expense management highlights a shift in operational focus. While revenue grew by 3.4%, the cost of consumption dropped sharply by nearly 30% year-on-year, suggesting improved procurement efficiency or changes in service mix. Conversely, the significant jump in employee benefits expenses (57.6% increase) indicates that the company is likely investing heavily in talent acquisition or retention, which aligns with the simultaneous approval of a new ESOP scheme. This suggests a long-term strategy to stabilize and grow its workforce despite near-term pressure on operating margins.

Upcoming AGM Details

The 6th Annual General Meeting is scheduled for September 18, 2026, at 2:30 P.M., to be conducted via Video Conferencing or Other Audio-Visual Means. The record date for determining eligibility to receive notices and vote is September 11, 2026. The register of members and share transfer books will remain closed from September 12, 2026, to September 18, 2026. CS Santhanakrishna Anuradha has been appointed as the scrutinizer for the AGM.